Destination Wealth Management Cerus Corp Transaction History

Destination Wealth Management

  • $3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$4.86 - $6.05 $10,449 - $13,007
-2,150 Closed
0 $0
Q3 2018

Nov 07, 2018
BUY
$6.89 - $7.78 $14,813 - $16,727
2,150 New
2,150 $16,000
Q2 2018

Jul 31, 2018
SELL
$5.19 - $7.25 $934 - $1,305
-180 Closed
0 $0
Q1 2018

Apr 05, 2018
BUY
$3.56 - $5.74 $640 - $1,033
180 New
180 $5,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Destination Wealth Management Portfolio

Follow Destination Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email